ALGINATE DE SODIUM / BICARBONATE DE SODIUM BIOGARAN 250 mg/133.5 mg per 5 ml, oral suspension in a vial bottle, 250 ml
Active ingredients: Sodium alginate, Sodium bicarbonate
Commercialized according to BDPM
Oral suspensionbottle, 250 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ALGINATE DE SODIUM / BICARBONATE DE SODIUM BIOGARAN 250 mg/133,5 mg pour 5 ml, suspension buvable en flacon
- Pharmaceutical form
- suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre brun de 250 ml avec cuillère-mesure polystyrène
- Marketing authorisation holder
- BIOGARAN
- Reimbursement according to BDPM
- 15%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 23 Jun 2022
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63517694CIP73605896CIP133400936058965Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BICARBONATE DE SODIUMsuspension | 133,5 mg · 5 ml de suspension buvable | SA |
| ALGINATE DE SODIUMsuspension | 250 mg · 5 ml de suspension buvable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.